Daymark Wealth Partners LLC Boosts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Daymark Wealth Partners LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 12.1% during the third quarter, Holdings Channel.com reports. The fund owned 2,583 shares of the company’s stock after purchasing an additional 279 shares during the quarter. Daymark Wealth Partners LLC’s holdings in HCA Healthcare were worth $1,050,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CreativeOne Wealth LLC acquired a new position in HCA Healthcare during the first quarter valued at approximately $231,000. New Mexico Educational Retirement Board increased its holdings in HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares in the last quarter. Kingswood Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the first quarter worth about $566,000. Teachers Retirement System of The State of Kentucky raised its holdings in shares of HCA Healthcare by 15.6% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock valued at $53,922,000 after buying an additional 26,919 shares during the period. Finally, Bessemer Group Inc. boosted its holdings in HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after acquiring an additional 2,584 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

HCA has been the topic of several analyst reports. Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Leerink Partners upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Morgan Stanley started coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Finally, Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Stock Up 0.2 %

HCA stock opened at $387.25 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $409.42. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market cap of $101.43 billion, a PE ratio of 19.30, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The firm’s 50-day simple moving average is $385.90 and its 200 day simple moving average is $346.88.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same period in the prior year, the company posted $4.29 EPS. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were issued a $0.66 dividend. The ex-dividend date was Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.68%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Insiders Place Their Bets

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.